We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.66%
2 Healthcare 21.01%
3 Consumer Discretionary 11.38%
4 Communication Services 10.4%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
326
DELISTED
Hologic
HOLX
$59K ﹤0.01%
879
– –
CMS icon
327
CMS Energy
CMS
$21.5B
$58K ﹤0.01%
975
– –
OMC icon
328
Omnicom Group
OMC
$22.7B
$58K ﹤0.01%
727
– –
CAH icon
329
Cardinal Health
CAH
$57.5B
$57K ﹤0.01%
994
– –
COR icon
330
Cencora
COR
$63.2B
$57K ﹤0.01%
502
– –
IEX icon
331
IDEX
IEX
$16.5B
$57K ﹤0.01%
257
– –
UNP icon
332
Union Pacific
UNP
$172B
$57K ﹤0.01%
+261
New +$58.1K
WYNN icon
333
Wynn Resorts
WYNN
$9.43B
$57K ﹤0.01%
469
– –
BXP icon
334
Boston Properties
BXP
$10.8B
$56K ﹤0.01%
488
– –
GPC icon
335
Genuine Parts
GPC
$19B
$56K ﹤0.01%
443
– –
O icon
336
Realty Income
O
$58B
$56K ﹤0.01%
861
-594
-41% -$39K
SUI icon
337
Sun Communities
SUI
$14.5B
$56K ﹤0.01%
329
– –
CBSH icon
338
Commerce Bancshares
CBSH
$8.37B
$55K ﹤0.01%
944
+685
+264% +$41.3K
ITW icon
339
Illinois Tool Works
ITW
$76.9B
$55K ﹤0.01%
+245
New +$56.1K
UAL icon
340
United Airlines
UAL
$36.2B
$54K ﹤0.01%
1,038
– –
MAS icon
341
Masco
MAS
$14.3B
$52K ﹤0.01%
890
– –
TDY icon
342
Teledyne Technologies
TDY
$28.3B
$52K ﹤0.01%
124
– –
MOH icon
343
Molina Healthcare
MOH
$10.5B
$51K ﹤0.01%
201
– –
LYFT icon
344
Lyft
LYFT
$6.33B
$50K ﹤0.01%
834
-1,820
-69% -$105K
WAB icon
345
Wabtec
WAB
$47.8B
$50K ﹤0.01%
608
– –
EMN icon
346
Eastman Chemical
EMN
$8.14B
$49K ﹤0.01%
+419
New +$50.3K
INCY icon
347
Incyte
INCY
$25.7B
$49K ﹤0.01%
582
– –
ADM icon
348
Archer Daniels Midland
ADM
$40.8B
$47K ﹤0.01%
+779
New +$49.4K
AXON
349
Axon Enterprise
AXON
$41.9B
$47K ﹤0.01%
265
– –
JBHT icon
350
JB Hunt Transport Services
JBHT
$25.7B
$47K ﹤0.01%
286
– –
12 13
14
15 16

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.